₩3,155.00 ($2.35)

-120.00 (-3.66%)

Weekly Expected Move ±17.9%

₩2025 ₩2590 ₩3155 ₩3720 ₩4285

KOE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 57 · ₩215.8B mcap · 55M float · 2.84% daily turnover

Revenue

$89.2B +10.2% ▲

5Y CAGR: +38.2%

Gross Profit

$41.7B +15.9% ▲

5Y CAGR: +33.3%

Operating Income

$10.7B -1.0% ▼

5Y CAGR: +34.6%

Net Income

$13.3B -48.2% ▼

EPS (Diluted)

$198.48 -40.6% ▼

EBITDA

$25.3B -4.7% ▼

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$19.4B	$25.2B	$42.3B	$81.0B	$89.2B
YoY Growth	+10.0%	+29.9%	+67.5%	+91.5%	+10.2%
Cost of Revenue	$9.8B	$14.0B	$27.0B	$45.0B	$47.5B
Gross Profit	$9.7B	$11.2B	$15.3B	$36.0B	$41.7B
Gross Margin	49.8%	44.5%	36.3%	44.5%	46.8%
R&D Expenses	$1.7B	$8.9B	$5.4B	$5.0B	$2.7B
SG&A Expenses	$1.8B	$12.8B	$19.5B	$7.6B	$8.9B
Operating Expenses	$8.7B	$22.5B	$24.9B	$25.2B	$31.0B
Operating Income	$948M	-$11.2B	-$10.1B	$10.8B	$10.7B
Operating Margin	4.9%	-44.5%	-23.9%	13.4%	12.0%
Interest Expense	$105M	$2.4B	$1.9B	$680M	$334M
Income Before Tax	$271M	-$225.9B	-$45.9B	$17.7B	$15.7B
Tax Expense	-$1.2B	-$49.6B	-$1.3B	-$8.4B	$2.4B
Net Income	$1.4B	-$176.3B	-$44.7B	$25.7B	$13.3B
Net Margin	7.3%	-698.1%	-105.7%	31.7%	14.9%
EPS (Diluted)	$26.35	$-3254.37	$-711.10	$334.00	$198.48
EBITDA	$2.2B	-$220.6B	-$38.8B	$26.5B	$25.3B
Shares Outstanding	54M	54M	63M	68M	67M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$23.5B	$25.8B	$25.4B	$24.6B	$22.3B	$23.6B	$20.7B	$24.6B
Cost of Revenue	$11.7B	$15.0B	$13.1B	$13.9B	$13.5B	$16.1B	$12.9B	$16.7B
Gross Profit	$11.9B	$10.8B	$12.4B	$10.8B	$8.8B	$7.5B	$7.8B	$7.9B
Gross Margin	50.4%	41.9%	48.6%	43.7%	39.3%	31.9%	37.7%	32.3%
R&D Expenses	$761M	$1.2B	$1.0B	$922M	$0	$1.4B	$1.3B	$1.1B
SG&A Expenses	$8.4B	$3.0B	$8.6B	$9.2B	$10.2B	$2.9B	$9.3B	$7.4B
Operating Expenses	$8.4B	$9.1B	$8.6B	$9.2B	$10.2B	$9.8B	$9.3B	$8.7B
Operating Income	$3.4B	$1.7B	$3.8B	$1.6B	-$1.4B	-$2.3B	-$1.5B	-$766M
Operating Margin	14.5%	6.7%	14.9%	6.5%	-6.3%	-9.6%	-7.1%	-3.1%
Interest Expense	$61M	$126M	$113M	$136M	$134M	$246M	$203M	$199M
Income Before Tax	$2.3B	$9.8B	$6.2B	$124M	$176M	-$2.2B	-$1.2B	-$322M
Tax Expense	$538M	$1.1B	$1.1B	-$157M	$541M	$755M	$132M	$1.4B
Net Income	$1.8B	$8.6B	$5.1B	$336M	-$187M	-$2.4B	-$1.0B	-$1.1B
Net Margin	7.8%	33.2%	19.9%	1.4%	-0.8%	-10.0%	-5.0%	-4.6%
EPS (Diluted)	$27.00	$127.10	$74.00	$5.00	$-3.00	$-37.91	$-16.55	$-16.52
EBITDA	$11.9B	$12.4B	$9.0B	$4.4B	$3.2B	-$259M	$2.1B	$2.4B
Shares Outstanding	68M	68M	68M	68M	62M	62M	62M	68M

256840.KQ KOE